Your browser doesn't support javascript.
loading
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes.
Montoro, Julia; Gallur, Laura; Merchán, Brayan; Molero, Antonieta; Roldán, Elisa; Martínez-Valle, Ferrán; Villacampa, Guillermo; Navarrete, Mayda; Ortega, Margarita; Castellví, Josep; Saumell, Silvia; Bobillo, Sabela; Bosch, Francesc; Valcárcel, David.
Afiliação
  • Montoro J; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Gallur L; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Merchán B; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Molero A; Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Roldán E; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Martínez-Valle F; Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Villacampa G; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Navarrete M; Department of Internal Medicine, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Ortega M; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Castellví J; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Saumell S; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Bobillo S; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Bosch F; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
  • Valcárcel D; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.
Ann Hematol ; 97(8): 1349-1356, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29572561
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Síndromes Mielodisplásicas Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Síndromes Mielodisplásicas Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article